Momentum Builds Across Programs with Key Data Milestones Expected in 2025Cemacabtagene Ansegedleucel (Cema-Cel): First-Line (1L) Consolidation in ...

Servier and The World Heart Federation (WHF) have announced that the duo has taken the lead in rallying support from ...

Privately-held French drugmaker Servier has announced the appointment of Nitza Thomasson as executive director, R&D Neurology.

He is currently Executive Director Research at Servier, where he manages the research centers in France, Denmark, Hungary and ...

In a study comparing the glioma tumors of firefighters and non-fighters, researchers found a mutational signature tied to exposure to haloalkanes, which are used in flame retardants, fire ...

During a Case-Based Roundtable® event, Robert Z. Orlowski, MD, PhD, discussed the case of a patient who had progression of ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Canadian researchers have developed an effective new technique for identifying aggressive medulloblastoma—the most common type of malignant brain tumour in children—and potentially sparing young ...

https://www.uksh.de/Das+UKSH/Presse/Presseinformationen/2025/Personalisierte+The... https://tu-dresden.de/med/mf/die-fakultaet/newsuebersicht/personalisierte-therap ...

Occupational and environmental exposures can put specific groups of people at higher risk of cancer, including firefighters.

Veeva Systems (NYSE: VEEV) today announced that 6 of the top 20 biopharmas have now chosen Veeva China CRM Suite to advance ...

Pieris Pharmaceuticals’ long-standing immuno-oncology alliance with Servier is being dissolved after a clinical trial of the lead drug in the alliance revealed a safety concern. In a Securities ...